Literature DB >> 22582016

Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.

Nobuhiko Kamada1, Yun-Gi Kim, Ho Pan Sham, Bruce A Vallance, José L Puente, Eric C Martens, Gabriel Núñez.   

Abstract

The virulence mechanisms that allow pathogens to colonize the intestine remain unclear. Here, we show that germ-free animals are unable to eradicate Citrobacter rodentium, a model for human infections with attaching and effacing bacteria. Early in infection, virulence genes were expressed and required for pathogen growth in conventionally raised mice but not germ-free mice. Virulence gene expression was down-regulated during the late phase of infection, which led to relocation of the pathogen to the intestinal lumen where it was outcompeted by commensals. The ability of commensals to outcompete C. rodentium was determined, at least in part, by the capacity of the pathogen and commensals to grow on structurally similar carbohydrates. Thus, pathogen colonization is controlled by bacterial virulence and through competition with metabolically related commensals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582016      PMCID: PMC3439148          DOI: 10.1126/science.1222195

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  19 in total

1.  The Per regulon of enteropathogenic Escherichia coli : identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler).

Authors:  J L Mellies; S J Elliott; V Sperandio; M S Donnenberg; J B Kaper
Journal:  Mol Microbiol       Date:  1999-07       Impact factor: 3.501

Review 2.  Citrobacter rodentium of mice and man.

Authors:  Rosanna Mundy; Thomas T MacDonald; Gordon Dougan; Gad Frankel; Siouxsie Wiles
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

3.  A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA.

Authors:  Jeannette Barba; Víctor H Bustamante; Mario A Flores-Valdez; Wanyin Deng; B Brett Finlay; José L Puente
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

4.  Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen.

Authors:  Lynn Bry; Michael B Brenner
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

5.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

6.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

Authors:  Claudia Lupp; Marilyn L Robertson; Mark E Wickham; Inna Sekirov; Olivia L Champion; Erin C Gaynor; B Brett Finlay
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

7.  Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing.

Authors:  Christian Hoffmann; David A Hill; Nana Minkah; Thomas Kirn; Amy Troy; David Artis; Frederic Bushman
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

8.  Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies.

Authors:  Christian Maaser; Michael P Housley; Mitsutoshi Iimura; Jennifer R Smith; Bruce A Vallance; B Brett Finlay; John R Schreiber; Nissi M Varki; Martin F Kagnoff; Lars Eckmann
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Utility of the Citrobacter rodentium infection model in laboratory mice.

Authors:  Diana Borenshtein; Megan E McBee; David B Schauer
Journal:  Curr Opin Gastroenterol       Date:  2008-01       Impact factor: 3.287

10.  Dissecting virulence: systematic and functional analyses of a pathogenicity island.

Authors:  Wanyin Deng; José L Puente; Samantha Gruenheid; Yuling Li; Bruce A Vallance; Alejandra Vázquez; Jeannette Barba; J Antonio Ibarra; Paul O'Donnell; Pavel Metalnikov; Keith Ashman; Sansan Lee; David Goode; Tony Pawson; B Brett Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

View more
  257 in total

1.  Microbiome: Pathogens and commensals fight it out.

Authors:  Rachel David
Journal:  Nat Rev Microbiol       Date:  2012-06-06       Impact factor: 60.633

Review 2.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

Review 3.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

Review 4.  Probiotics or pro-healers: the role of beneficial bacteria in tissue repair.

Authors:  Jovanka Lukic; Vivien Chen; Ivana Strahinic; Jelena Begovic; Hadar Lev-Tov; Stephen C Davis; Marjana Tomic-Canic; Irena Pastar
Journal:  Wound Repair Regen       Date:  2018-02-09       Impact factor: 3.617

Review 5.  Microbiota modulation of myeloid cells in cancer therapy.

Authors:  Romina S Goldszmid; Amiran Dzutsev; Sophie Viaud; Laurence Zitvogel; Nicholas P Restifo; Giorgio Trinchieri
Journal:  Cancer Immunol Res       Date:  2015-02       Impact factor: 11.151

6.  The gut microbiome: a new frontier for alcohol investigation.

Authors:  Gail A Cresci
Journal:  Alcohol Clin Exp Res       Date:  2015-04-23       Impact factor: 3.455

Review 7.  The interplay between the intestinal microbiota and the immune system.

Authors:  Yuk Man Kevin Lei; Lekha Nair; Maria-Luisa Alegre
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-11-11       Impact factor: 2.947

8.  Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Sabita Roy
Journal:  Gut Microbes       Date:  2019-08-05

Review 9.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

10.  NADPH oxidase-derived H2O2 subverts pathogen signaling by oxidative phosphotyrosine conversion to PB-DOPA.

Authors:  Luis A Alvarez; Lidija Kovačič; Javier Rodríguez; Jan-Hendrik Gosemann; Malgorzata Kubica; Gratiela G Pircalabioru; Florian Friedmacher; Ada Cean; Alina Ghişe; Mihai B Sărăndan; Prem Puri; Simon Daff; Erika Plettner; Alex von Kriegsheim; Billy Bourke; Ulla G Knaus
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.